The impact of gut microbiome-targeted therapy on liver enzymes in patients with nonalcoholic fatty liver disease: an umbrella meta-analysis

Amini-Salehi, E; Hassanipour, S; Keivanlou, MH; Shahdkar, M; Goorabzarmakhi, MO; Vakilpour, A; Joukar, F; Hashemi, M; Sattari, N; Javid, M; Mansour-Ghanaei, F

Mansour-Ghanaei, F (通讯作者),Guilan Univ Med Sci, Gastrointestinal & Liver Dis Res Ctr, Razi Hosp, Sardar Jangle Ave,POB 41448-95655, Rasht, Iran.

NUTRITION REVIEWS, 2023; ():

Abstract

Context Nonalcoholic fatty liver disease (NAFLD) is considered the leading cause of chronic liver disease worldwide. To date, no confirmed medication ......

Full Text Link